The average one-year price target for Minerva Neurosciences (NasdaqCM:NERV) has been revised to $7.40 / share. This is an increase of 61.11% from the prior estimate of $4.59 dated February 21, 2026. The price target is an average of many targets provided by an
The average one-year price target for Minerva Neurosciences (NasdaqCM:NERV) has been revised to $7.40 / share. This is an increase of 61.11% from the prior estimate of $4.59 dated February 21, 2026. The price target is an average of many targets provided by an
The average one-year price target for Context Therapeutics (NasdaqCM:CNTX) has been revised to $5.78 / share. This is an increase of 13.33% from the prior estimate of $5.10 dated February 21, 2026. The price target is an average of many targets provided by ana
The average one-year price target for Context Therapeutics (NasdaqCM:CNTX) has been revised to $5.78 / share. This is an increase of 13.33% from the prior estimate of $5.10 dated February 21, 2026. The price target is an average of many targets provided by ana
The average one-year price target for Shimmick (NasdaqCM:SHIM) has been revised to $5.61 / share. This is an increase of 22.22% from the prior estimate of $4.59 dated February 21, 2026. The price target is an average of many targets provided by analysts. The l
The average one-year price target for Shimmick (NasdaqCM:SHIM) has been revised to $5.61 / share. This is an increase of 22.22% from the prior estimate of $4.59 dated February 21, 2026. The price target is an average of many targets provided by analysts. The l
The average one-year price target for Nature's Sunshine Products (NasdaqCM:NATR) has been revised to $33.66 / share. This is an increase of 46.67% from the prior estimate of $22.95 dated February 21, 2026. The price target is an average of many targets provide
The average one-year price target for Nature's Sunshine Products (NasdaqCM:NATR) has been revised to $33.66 / share. This is an increase of 46.67% from the prior estimate of $22.95 dated February 21, 2026. The price target is an average of many targets provide
The average one-year price target for Beiersdorf Aktiengesellschaft (XTRA:BEI) has been revised to 104,38 € / share. This is a decrease of 11.60% from the prior estimate of 118,08 € dated February 21, 2026. The price target is an average of many targets provid
The average one-year price target for Beiersdorf Aktiengesellschaft (XTRA:BEI) has been revised to 104,38 € / share. This is a decrease of 11.60% from the prior estimate of 118,08 € dated February 21, 2026. The price target is an average of many targets provid
(RTTNews) - Indian shares are seen opening lower on Friday, though overall losses may remain capped somewhat after U.S. President Donald Trump extended the pause on U.S. strikes against Iran's energy infrastructure by 10 days, adding talks with Iran were going "very well."
(RTTNews) - Indian shares are seen opening lower on Friday, though overall losses may remain capped somewhat after U.S. President Donald Trump extended the pause on U.S. strikes against Iran's energy infrastructure by 10 days, adding talks with Iran were going "very well."